MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gassur.2024.01.007

Медицинская библиотека · Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2024

Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma.

Akumuo Rita C, Reddy Sai P, Westwood Caroline, Devarajan Karthik, Barrak Dany, Reddy Sanjay S, Villano Anthony M

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Differential responses to neoadjuvant therapy (NAT) exist in pancreatic ductal adenocarcinoma (PDAC); however, contributing factors are poorly understood. Tobacco smoke is a common risk factor for PDAC, with nicotine-induced chemoresistance observed in other cancers. This study aimed to explore the potential association between tobacco use and NAT efficacy in PDAC.

METHODS

A single-center, retrospective analysis was conducted that included all consecutive patients with PDAC who underwent surgical resection after NAT with a documented smoking history (N = 208). NAT response was measured as percentage fibrosis in the surgical specimen. Multivariable models controlled for covariates and survival were modeled using the Kaplan-Meier method.

RESULTS

Postoperatively, major responses to NAT (>95% fibrosis) were less frequently observed in smokers than in nonsmokers (13.7% vs 30.4%, respectively; P = .021). Pathologic complete responses were similarly less frequent in smokers than in nonsmokers (2.1% vs 9.9%, respectively; P = .023). On multivariate analysis controlling for covariates, smoking history remained independently associated with lower odds of major fibrosis (odds ratio [OR], 0.25; 95% CI, 0.10-0.59; P = .002) and pathologic complete response (OR, 0.21; 95% CI, 0.03-0.84; P = .05). The median overall survival was significantly longer in nonsmokers than in smokers (39.1 vs 26.6 months, respectively; P = .05).

CONCLUSION

Tobacco use was associated with diminished pathologic responses to NAT. Future research to understand the biology underlying this observation is warranted and may inform differential NAT approaches or counseling among these populations.

Для цитирования: Akumuo Rita C, Reddy Sai P, Westwood Caroline, Devarajan Karthik, Barrak Dany, Reddy Sanjay S, Villano Anthony M. Smoking history is associated with reduced efficacy of neoadjuvant therapy in pancreatic adenocarcinoma.. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2024. DOI: 10.1016/j.gassur.2024.01.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.